Roivant Sciences Ltd. (ROIV) stock analysis

ROIV · Roivant Sciences Ltd.

Latest recorded price: USD 38.61

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -46.9%, free cash flow margin -9,183.5%, ROIC -659.8%. The model flags 3 risk signals for this company (2 high severity).

Similar companies in Healthcare